Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117628422 | 11762842 | 2 | F | 20120824 | 20160819 | 20151120 | 20160819 | EXP | BR-BRISTOL-MYERS SQUIBB COMPANY-18822858 | BRISTOL MYERS SQUIBB | 0.00 | DY | M | Y | 2.52000 | KG | 20160819 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117628422 | 11762842 | 1 | SS | EFAVIRENZ | EFAVIRENZ | 1 | Transplacental | 600 MG, QD | 71400 | MG | 0 | 600 | MG | QD | |||||
| 117628422 | 11762842 | 2 | PS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Transplacental | 400 MG, QD | U | 21567 | 400 | MG | QD | ||||||
| 117628422 | 11762842 | 3 | C | LAMIVUDINE AND ZIDOVUDINE | LAMIVUDINEIDOVUDINE | 1 | Transplacental | 1 DF, BID | 2872 | DF | U | 0 | 1 | DF | BID | ||||
| 117628422 | 11762842 | 4 | C | LOPINAVIR + RITONAVIR | LOPINAVIRRITONAVIR | 1 | Transplacental | 1 DF, BID | U | 0 | 1 | DF | BID | ||||||
| 117628422 | 11762842 | 5 | C | NEVIRAPINE. | NEVIRAPINE | 1 | Transplacental | 200 MG, BID | 41200 | MG | U | 0 | 200 | MG | BID | ||||
| 117628422 | 11762842 | 6 | C | SCOPOLAMINE | SCOPOLAMINE | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117628422 | 11762842 | 1 | Product used for unknown indication |
| 117628422 | 11762842 | 2 | Product used for unknown indication |
| 117628422 | 11762842 | 3 | Product used for unknown indication |
| 117628422 | 11762842 | 4 | Product used for unknown indication |
| 117628422 | 11762842 | 5 | Product used for unknown indication |
| 117628422 | 11762842 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117628422 | 11762842 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117628422 | 11762842 | Foetal exposure during pregnancy | |
| 117628422 | 11762842 | Infection | |
| 117628422 | 11762842 | Jaundice neonatal | |
| 117628422 | 11762842 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117628422 | 11762842 | 1 | 20080919 | 20090115 | 0 | |
| 117628422 | 11762842 | 2 | 20090115 | 20111107 | 0 | |
| 117628422 | 11762842 | 3 | 20080919 | 20120824 | 0 | |
| 117628422 | 11762842 | 4 | 20120117 | 20120514 | 0 | |
| 117628422 | 11762842 | 5 | 20120514 | 20120824 | 0 | |
| 117628422 | 11762842 | 6 | 201206 | 20120823 | 0 |